BioSpace News Archive

Business

ABK Biomedical Appoints Michael J. Mangano as President and Chief Executive Officer

ABK Biomedical, Inc., a company dedicated to the research, development and commercialization of innovative embolic therapies, has announced the appointment of Michael J. Mangano as president and chief executive officer.

July 30, 2018
·
3 min read
Business

Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer

Tenaya Therapeutics is a preclinical-stage biotechnology company focused on discovery and development of novel therapies for heart failure

July 30, 2018
·
3 min read
FDA

Nektar Therapeutics Announces New Drug Application for NKTR-181 Accepted for Review by FDA

NKTR-181 is a First-in-Class Investigational Opioid to Treat Chronic Low Back Pain in Adult Patients New to Opioid Therapy

July 30, 2018
·
6 min read
Lone Star Bio

InMode Aesthetic Solutions: Dr. Jennifer Owen is Among First to Offer Votiva Feminine Wellness Treatments in Lubbock, TX

Local OB/GYN Providing Patients with Votiva to improve internal and external vaginal health concerns

July 30, 2018
·
2 min read
Business

SFC Fluidics, Inc. Announces Partnership with JDRF to Develop Patch Pump with Open-Protocol Communication

SFC Fluidics, Inc. announced a new Industry Discovery and Development Partnership supported by JDRF, the leading global organization funding type 1 diabetes (T1D) research.

July 30, 2018
·
4 min read
Policy

Minerva Surgical Announces Outcome in Hologic Patent Lawsuit

Minerva’s Product Remains Commercially Available

July 30, 2018
·
3 min read
Lone Star Bio

Castle Biosciences Presents Data Demonstrating the DecisionDx-Melanoma Test Improved AJCC-Based Risk Prediction for Melanoma Recurrence and Metastasis

Test demonstrated high technical reliability in over 17,000 clinical orders

July 30, 2018
·
5 min read
Drug Development

Presbyopia Therapies Announces Primary Safety and Efficacy Endpoints met in a Phase IIb study of its Topical PRX Ophthalmic Solution for the Treatment of Presbyopia

Presbyopia Therapies, LLC announced that the primary efficacy and safety endpoints have been met in a Phase IIb study of its PRX ophthalmic solution.

July 30, 2018
·
3 min read
Deals

Cardax Announces Successful Completion of Warrant Exchange Offer

Company Raises $1.44 Million in Non-Dilutive Financing

July 30, 2018
·
3 min read
FDA

DURECT Announces FDA Approval of Indivior’s PERSERIS™ (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults

Approval triggers $5 million milestone payment to DURECT and future earn-out payments based on U.S. net sales

July 30, 2018
·
4 min read